Clinical Trials Directory

Trials / Conditions / Ph+ ALL

Ph+ ALL

7 registered clinical trials studyying Ph+ ALL — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingChemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
NCT07493161
Institute of Hematology & Blood Diseases Hospital, ChinaN/A
Not Yet RecruitingEfficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed
NCT07443488
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
NCT06051409
Ascentage Pharma Group Inc.Phase 3
UnknownA Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Pos
NCT05603156
Institute of Hematology & Blood Diseases Hospital, ChinaN/A
TerminatedPonatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
NCT04554459
Institute of Hematology and Blood Transfusion, Czech RepublicPhase 2
CompletedIclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphobla
NCT03678454
Incyte Biosciences Benelux—
TerminatedDonor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01028716
Fred Hutchinson Cancer CenterPhase 2